arrow
T

Timothy M. Uyeki

Centers for Disease Control and Prevention
H指数:95
被引数:4.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influenza Antiviral Treatment among Influenza Outpatients, PCORnet, 2022–2025 Influenza Seasons

流感的抗病毒治疗在流感门诊患者中的应用,PCORnet,2022–2025流感季节

2026-10-290
OAAI
Human infections with highly pathogenic avian influenza A(H5N1) viruses in the United States from March 2024 to May 2025

M. A. Rolfes et al., Nat. Med. 10.1038/s41591-025-03905-2 (2025).

2025-07-250
PRE
Epidemiology of Human Metapneumovirus Infection in a Community Setting, Seattle, Washington, USA

人类偏肺病毒感染在社区环境下的流行病学,西雅图,华盛顿州,美国

2025-07-154
OA
Neutralizing Antibody Response to Influenza A(H5N1) Virus in Dairy Farm Workers, Michigan, USA

中和抗体对甲型禽流感病毒(H5N1)在密歇根州乳牛场工人中的反应,密歇根州,美国

2025-04-010
PRE
SARS-CoV-2 Diversity and Transmission on a University Campus across Two Academic Years during the Pandemic
2025-01-030
PRE
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study

早期奥司他韦治疗对甲型流感住院成人患者的益处: 一项观察性研究

2024-11-281
OA
Perceptions and Barriers to Outpatient Antiviral Therapy for COVID-19 and Influenza as Observed by Infectious Disease Specialists in North America: Results of an Emerging Infections Network (EIN) Survey, February 2024
2024-11-080
OA
Clinical and Genomic Epidemiology of Coxsackievirus A21 and Enterovirus D68 in Homeless Shelters, King County, Washington, USA, 2019-2021
2024-11-010
PRE
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012-2019
2024-08-226
OA
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

SARS-CoV-2 RNA和核衣壳抗原是与严重疾病结局相关的血液生物标志物,对Remdesivir的反应有所改善

2024-04-243
OA